Clinical Trial Update: A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety of tranexamic acid in patients with chronic subdural hematoma has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: St. Joseph's Hospital and Medical Center, Phoenix | Conditions: Subdural Hematoma | Phase 4 | Status: COMPLETED | Results posted: 2021-11-09